Quantitative phase imaging of erythrocyte in epilepsy patients.
Aysun ÜnalÖzlem KocahanBengü AltunanAslı Aksoy GündoğduMerve UyanıkSerhat ÖzderPublished in: Microscopy research and technique (2020)
The present study focuses on the quantitative phase imaging of erythrocytes with the aim to compare the morphological differences between epilepsy patients under antiepileptic treatment, who have no other disease which may affect the erythrocyte morphology, and the healthy control group. The white light diffraction phase microscopy (WDPM) has been used to obtain the interferogram of the erythrocyte surfaces. The continuous wavelet transform with Paul wavelet has been chosen to calculate the surface profiles from this interferogram image. For the determination of alteration in morphology, besides WDPM, erythrocyte surfaces have been investigated by light microscope and scanning electron microscope. In this way, it has been possible to see the difference in terms of precision and implementation between the most commonly used methods with regard to the quantitative phase imaging. Erythrocytes from all the samples have been examined and displayed in both two- and three-dimensional way. We have observed that erythrocytes of patients with effective antiepileptic blood levels were more affected in morphology than healthy subjects. When we compared the erythrocyte morphological changes of patients who received monotherapy or polytherapy, no difference was observed. In conclusion, antiepileptic drugs (AEDs) cause red blood cell (RBC) morphological changes and a combined usage of WDPM with Paul wavelet and light microscopy methods are very convenient for studying the erythrocyte morphologies on multiple patients.
Keyphrases
- high resolution
- ejection fraction
- newly diagnosed
- red blood cell
- healthcare
- clinical trial
- primary care
- staphylococcus aureus
- mass spectrometry
- escherichia coli
- single molecule
- machine learning
- photodynamic therapy
- high throughput
- chronic kidney disease
- biofilm formation
- patient reported
- replacement therapy
- label free
- tandem mass spectrometry
- solid phase extraction